Hemotune raises €2.8M Pre-Seed round
1 May 2017· Zurich, Switzerland· health, medtech, nanotechnology, biotech, magnetic_separation, b2b, software_hardware
Hemotune was accelerated by Wyss Zurich, indicating early-stage development and acceleration funding.
Investors
LeadWyss Zurich
About Hemotune
Stage
Series B
Headquarters
Zurich, Switzerland
Founded
2017
Team Size
21–50
Sectors
healthmedtechnanotechnologybiotechmagnetic_separationb2bsoftware_hardware